Media Coverage

2022

02/08/2022

American doctors give tick to Proteomics kidney test – The West Australian

01/08/2022

Boost for Proteomics in fight against painful disorder – The West Australian

28/06/2022

QIMR Berghofer Licenses Esophageal Cancer Blood Biomarkers to Proteomics International – Precision Oncology News

21/06/2022

Proteomics International (ASX:PIQ) secures licence for oesophageal cancer biomarkers – The Market Herald

16/06/2022

Pilot test kit takes Proteomics step closer to sales – The West Australian

16/06/2022

Proteomics International Laboratories (ASX:PIQ) completes PromarkerD manufacturing tech transfer – The Market Herald

06/06/2022

Study boosts diagnostic potential for Proteomics – The West Australian

12/05/2022

Proteomics International awarded funding to support diabetic kidney disease test development – The Market Herald

12/04/2022

New Clinical Advisory Board to support PromarkerD global rollout – Yahoo! Finance

24/03/2022

Indian IP win gives Proteomics massive global cover – The West Australian

22/02/2022

Proteomics eyes Medicare for rebate inclusion – The West Australian

04/02/2022

Study results emerge for Proteomics International Laboratories’ latest cancer diagnostic test – The Sentiment

2021

16/12/2021

Proteomics wins biotech testing contract – The West Australian

14/12/2021

Proteomics International Laboratories (ASX:PIQ) receives $1.2 million R&D incentive – The Market Herald

23/11/2021

Proteomics enters lucrative UK market for kidney test – The West Australian

Subscribe
  • This field is for validation purposes and should be left unchanged.